{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:32:17Z","timestamp":1790202737965,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373257"],"award-info":[{"award-number":["81373257"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703668"],"award-info":[{"award-number":["81703668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Fund","doi-asserted-by":"publisher","award":["S2013010015609"],"award-info":[{"award-number":["S2013010015609"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Fund","doi-asserted-by":"publisher","award":["2017A030310396"],"award-info":[{"award-number":["2017A030310396"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejmech.2018.04.040","type":"journal-article","created":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T20:50:54Z","timestamp":1524430254000},"page":"195-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Synthesis, cytotoxicity and structure-activity relationship of indolizinoquinolinedione derivatives as DNA topoisomerase IB catalytic inhibitors"],"prefix":"10.1016","volume":"152","author":[{"given":"Qian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-Mao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Quan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Shu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-1503","authenticated-orcid":false,"given":"Lin-Kun","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.04.040_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib2","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.279.5356.1534","article-title":"A\u00a0model for the mechanism of human topoisomerase I","volume":"279","author":"Stewart","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.04.040_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/379225a0","article-title":"Structure and mechanism of DNA topoisomerase II","volume":"379","author":"Berger","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.04.040_bib4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","article-title":"Roles of eukaryotic topoisomerases in transcription, replication and genomic stability","volume":"17","author":"Pommier","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.04.040_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143730","article-title":"Time-dependent and organ-specific changes in mitochondrial function, mitochondrial DNA integrity, oxidative stress and mononuclear cell infiltration in a mouse model of burn injury","volume":"10","author":"Szczesny","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.04.040_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/cb300648v","article-title":"Drugging topoisomerases: lessons and challenges","volume":"8","author":"Pommier","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.04.040_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase I inhibitors: camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2018.04.040_bib8","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1021\/cr900097c","article-title":"DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition","volume":"109","author":"Pommier","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.04.040_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.04.040_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrc3892","article-title":"Topoisomerase-mediated chromosomal break repair: an emerging player in many games","volume":"15","author":"Ashour","year":"2015","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2018.04.040_bib11","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1021\/bi1009419","article-title":"A\u00a0novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2\/M phase cell cycle arrest to K562 cells","volume":"49","author":"Wu","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2018.04.040_bib12","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1158\/0008-5472.CAN-07-1615","article-title":"Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topoisomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death","volume":"67","author":"Ganguly","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.04.040_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejmech.2015.07.007","article-title":"Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors","volume":"101","author":"Yu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib14","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1021\/acs.jafc.7b01762","article-title":"Meroterpenoids with antitumor activities from guava (Psidium guajava)","volume":"65","author":"Qin","year":"2017","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib15","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","article-title":"Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I","volume":"260","author":"Hsiang","year":"1985","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib16","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1158\/1078-0432.CCR-10-0542","article-title":"Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment","volume":"17","author":"Kurtzberg","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.04.040_bib17","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1158\/0008-5472.CAN-07-0938","article-title":"Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance","volume":"67","author":"Antony","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.04.040_bib18","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1021\/bi00163a015","article-title":"Induction of mammalian DNA topoisomerase I-mediated DNA cleavage by antitumor indolocarbazole derivatives","volume":"31","author":"Yamashita","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2018.04.040_bib19","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/cr.2017.54","article-title":"Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation","volume":"27","author":"Lian","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2018.04.040_bib20","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.bmc.2008.02.036","article-title":"Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives","volume":"16","author":"Cheng","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib21","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1002\/ejoc.200600317","article-title":"Regioselectivity in the multi-component synthesis of indolizinoquinoline-5,12-dione derivatives","volume":"18","author":"Defant","year":"2006","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib22","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1016\/j.ejmech.2011.07.042","article-title":"Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives","volume":"46","author":"Wu","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib23","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1016\/j.tet.2004.04.041","article-title":"Simple preparation of 7-alkylamino-2-methylquinoline-5,8-diones: regiochemistry in nucleophilic substitution reactions of the 6- or 7-bromo-2-methylquinoline-5,8-dione with amines","volume":"60","author":"Choi","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.04.040_bib24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ejmech.2012.06.046","article-title":"New quinoline-5,8-dione and hydroxynaphthoquinone derivatives inhibit a chloroquine resistant Plasmodium falciparum strain","volume":"54","author":"Hussain","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib25","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1016\/j.ejmech.2010.05.048","article-title":"Synthesis and antiproliferative activity of indolizinophthalazine-5,12-dione derivatives, DNA topoisomerase IB inhibitors","volume":"45","author":"Shen","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib26","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1071\/CH09580","article-title":"Design, synthesis, and cytotoxicity of indolizinoquinoxaline-5,12-dione derivatives, novel DNA topoisomerase IB inhibitors","volume":"63","author":"Shen","year":"2010","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib27","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1093\/nar\/15.16.6713","article-title":"DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators","volume":"15","author":"Pommier","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2018.04.040_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.bb.10.060181.000511","article-title":"The interaction of intercalating drugs with nucleic acids","volume":"10","author":"Berman","year":"1981","journal-title":"Annu. Rev. Biophys. Bioeng."},{"key":"10.1016\/j.ejmech.2018.04.040_bib29","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1158\/0008-5472.CAN-06-4554","article-title":"Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses","volume":"67","author":"Miao","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.04.040_bib30","first-page":"1964","article-title":"Characterization of a novel topoisomerase I mutation from a camptothecin resistant human prostate cancer cell line","volume":"61","author":"Urasaki","year":"2001","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.04.040_bib31","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1073\/pnas.242259599","article-title":"The mechanism of topoisomerase I poisoning by a camptothecin analog","volume":"99","author":"Staker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.04.040_bib32","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1021\/jm049146p","article-title":"Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex","volume":"48","author":"Staker","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib33","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1021\/mp200261n","article-title":"The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy","volume":"8","author":"Wu","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2018.04.040_bib34","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1021\/acs.jmedchem.6b00605","article-title":"Jatrophane diterpenoids as modulators of P-Glycoprotein-Dependent multidrug resistance (MDR): advances of structure-activity relationships and discovery of promising MDR reversal agents","volume":"59","author":"Zhu","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.040_bib35","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1073\/pnas.78.6.3487","article-title":"Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei","volume":"78","author":"Liu","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.04.040_bib36","first-page":"936","article-title":"Evaluation of a tetrazolium-based semiautomated colorimetrie assay: assessment of chemosensitivity testing","volume":"47","author":"Carmichael","year":"1987","journal-title":"Canc. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830374X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830374X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T17:08:25Z","timestamp":1661015305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341830374X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":36,"alternative-id":["S022352341830374X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.040","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, cytotoxicity and structure-activity relationship of indolizinoquinolinedione derivatives as DNA topoisomerase IB catalytic inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}